You would have to think that a large cap pharma would be prepared to pay 2 to 3 times the Principia outlay (assuming the trial results are as good as we think they will be).
My opinion only. DYOR.
- Forums
- ASX - By Stock
- Ann: First patient treated in ACW XanaMIA ph 2b Alzheimers trial
You would have to think that a large cap pharma would be...
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
6.3¢ |
Change
0.003(5.00%) |
Mkt cap ! $174.3M |
Open | High | Low | Value | Volume |
6.0¢ | 6.8¢ | 5.8¢ | $1.195M | 18.73M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 103120 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.4¢ | 369515 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 103120 | 0.062 |
2 | 65250 | 0.061 |
1 | 460000 | 0.060 |
2 | 969610 | 0.059 |
4 | 186771 | 0.058 |
Price($) | Vol. | No. |
---|---|---|
0.064 | 369515 | 1 |
0.066 | 405217 | 2 |
0.067 | 338988 | 5 |
0.068 | 207426 | 3 |
0.069 | 381007 | 4 |
Last trade - 15.28pm 03/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
TON
TRITON MINERALS LTD
Adrian Costello, Executive Director
Adrian Costello
Executive Director
Previous Video
Next Video
SPONSORED BY The Market Online